Straightline Group
OSCR icon

Straightline Group’s Oscar Health OSCR Stock Holding History

Straightline Group’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,413
Closed -$246K – 20
2026
Q1 		$246K Buy
21,413
+1,644
+8% +$23.2K 0.12% 15
2025
Q4 		$310K Buy
19,769
+1,200
+6% +$20.8K 0.17% 15
2025
Q3 		$364K Buy
18,569
+487
+3% +$8.03K 0.21% 12
2025
Q2 		$388K Buy
18,082
+640
+4% +$9.5K 0.24% 11
2025
Q1 		$225K Buy
17,442
+2,170
+14% +$32.2K 0.15% 12
2024
Q4 		$205K Buy
+15,272
New +$246K 0.13% 41

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Thrive Capital Management (New York)
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Straightline Group's OSCR Position: Q2 2026 in Review

Straightline Group sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 21,413 shares — an estimated $246K sold.

Straightline Group first reported a position in OSCR in Q4 2024 and held it in 6 quarters. The position peaked at $388K in Q2 2025. 406 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Straightline Group reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Straightline Group sold 21,413 Oscar Health shares in Q2 2026, an estimated $246K.
  • Straightline Group first reported a position in Oscar Health in Q4 2024 and held it in 6 quarters.
  • Straightline Group's Oscar Health position peaked at $388K in Q2 2025.
  • 406 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Straightline Group's 13F filing for Q2 2026, filed 14 Aug 2026.